Latest News Archive

Please select Category, Year, and then Month to display items
Categories
UFS News Media Release Research
Years
2017 2018 2019 2020 2021 2022 2023 2024
Months
January February March April May June July August September October November December
Previous Archive
14 June 2018 Photo Supplied
Next Chapter Green Ribbon campaign addresses mental health
Members of Next Chapter and UFS Student counselling are working together to address mental health issues.
Next Chapter, a student support group at the UFS presented the Green Ribbon campaign, pledging their support to students and providing them with assistance in coping with life events that stimulate stress and contribute negatively to their mental health. The team aims to break the stigma surrounding mental health care, and continually assist students with mental health-related issues that they struggle with daily.

The Green Ribbon represents mental health awareness, which is a pressing matter for students and is the type of support students need in a stressful university environment. The campaign focuses on teaching students how to cope with life events that stimulate stress, and contribute negatively to their mental health.
 
A discussion by Dr Ancel George: practising clinical psychologist and lecturer from the UFS Department of Psychology, and Dr Mellissa Barnaschone: Director of UFS Student Counselling, took place, where talks were prominent about creating an inclusive environment for UFS students.

The panel shared a few tips on how students should work towards managing stress, and motivated them for the main mid-year examinations.
 
The follow-up Exam Cram Workshop, presented by Nadia Cloete and Lize Wolmarans, that combined time and stress management, took place on 2 June 2018, and saw students receiving advice on how to approach various issues during the examination period.
 
Mental health awareness does not end with the campaign and Next Chapter’s slogan “Your story continues” encourages students to regularly wear and commemorate the green ribbon in support of continual mental healthcare.
 
Should you have any enquiries or input for the ongoing campaign, contact the Next Chapter team on ufsnextchapter@gmail.com, or further email Tshepang Mahlatsi, founder of Next Chapter on tshepangmahlatsi767@gmail.com

News Archive

Researchers receive study grant for research into Congo Fever
2015-03-10

UFS researchers will be contributing significantly to the search for a vaccine against the deadly tick-borne disease known as Congo Fever.

Prof Felicity Burt from the Department of Medical Microbiology and Virology was recently awarded a research grant by the National Health Laboratory Service (NHLS) to study candidate vaccines for Crimean-Congo heamorrhagic fever (CCHF) virus and other arboviruses.

Arboviruses are viruses transmitted by mosquitoes, ticks, or other arthropods.

Prof Burt is an internationally-recognised expert on the Crimean-Congo haemorrhagic fever (CCHF). The Crimean-Congo haemorrhagic fever (CCHF) virus is a tick-borne virus that is associated with severe haemorrhagic disease in South Africa and other parts of Africa, Asia, and eastern Europe. Her interests focus on medically significant viruses that are transmitted by ticks and mosquitoes. Her research group is involved in determining the immune responses that are induced by different viral proteins.

Crimean-Congo haemorrhagic fever (CCHF) virus, a tick- borne virus found in Africa, Asia, the Balkans, and eastern Europe, causes severe viral haemorrhagic fever outbreaks.

Although a number of tick species are capable of becoming infected with CCHF virus, ticks of the genus Hyalomma, commonly referred to in SA as the “bont-legged ticks”, are the principal vector. The ticks have distinctive brown and white bands on their legs.

In February 1981, the first case of CCHF was recognised in South Africa (SA). To date, there have been nearly 200 cases of CCHF infection in SA with a 20% fatality rate. The majority of cases occurring in SA were in patients from the Northern Cape and Free State provinces.

“The funding that has been awarded will be used to profile immune responses against CCHF viral proteins, and investigate mechanisms and strategies to enhance these immune responses. We hope that the study will contribute knowledge towards the development of a vaccine against this medically significant virus.”

For more information or enquiries contact news@ufs.ac.za.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept